Skip to main content
SpringerLink
Log in

Cardiac Management

  • Chapter
  • First Online:
Diagnosis and Management of Marfan Syndrome

  • 1827 Accesses

Abstract

Marfan syndrome (MFS) is a disease in which connective tissue becomes weak because of genetic mutation, resulting in aortic dilatation, aneurysm, dissection, aortic regurgitation and mitral valve prolapse.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366:1965–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Radke RM, Baumgartner H. Diagnosis and treatment of Marfan syndrome: an update. Heart. 2014;100:1382–91.

    Article  PubMed  Google Scholar 

  3. Chiu HH, Wu MH, Chen HC, et al. Epidemiological profile of Marfan syndrome in a general population: a national database study. Mayo Clin Proc. 2014;89:34–42.

    Article  PubMed  Google Scholar 

  4. Pannu H, Tran-Fadulu V, Milewicz DM. Genetic basis of thoracic aortic aneurysms and aortic dissections. Am J Med Genet C Semin Med Genet. 2005;139C:10–6.

    Article  CAS  PubMed  Google Scholar 

  5. Cañadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome. Part 1: pathophysiology and diagnosis. Nat Rev Cardiol. 2010;7:256–65.

    PubMed  Google Scholar 

  6. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35:2873–926.

    Article  PubMed  Google Scholar 

  7. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476–85.

    Article  CAS  PubMed  Google Scholar 

  8. Evangelista A, Flachskampf FA, Erbel R, et al. Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr. 2010;11:645–58.

    Article  PubMed  Google Scholar 

  9. Campens L. Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. Am J Cardiol. 2014;114:914–20.

    Article  PubMed  Google Scholar 

  10. Mulder BJM. The distal aorta in the Marfan syndrome. Neth Heart J. 2008;16:382–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Engelfriet PM, Boersma E, Tijssen JGP, et al. Beyond the root: dilatation of the distal aorta in Marfan’s syndrome. Heart. 2006;92:1238–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ammash NM, Sundt TM, Connolly HM. Marfan syndrome - diagnosis and management. Curr Probl Cardiol. 2008;33(1):7–39.

    Google Scholar 

  13. Januzzi JL. Comparison of aortic dissection in patient with and without Marfan’s syndrome. Am J Cardiol. 2004;94:400–2.

    Article  PubMed  Google Scholar 

  14. Januzzi JL. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004;43:665–9.

    Article  PubMed  Google Scholar 

  15. Alpendurada F. Evidence for Marfan cardiomyopathy. Eur J Heart Fail. 2010;12:1085–91.

    Article  PubMed  Google Scholar 

  16. Judge DP. Mitral valve disease in Marfan syndrome. J Cardiovasc Trans Res. 2011;4:741–7.

    Article  Google Scholar 

  17. Weyman AE, Scherrer-Crosbie M. Marfan syndrome and mitral valve prolapse. J Clin Invest. 2004;114:1543–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rybczynski M, Treede H. Predictors of outcome of mitral valve prolapse in patients with the Marfan syndrome. Am J Cardiol. 2011;107:268–74.

    Article  PubMed  Google Scholar 

  19. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117–21.

    Google Scholar 

  20. Lundby R. The pulmonary artery in patients with Marfan syndrome: a cross-sectional study. Genet Med. 2012;14:922–7.

    Article  PubMed  Google Scholar 

  21. De Backer JF, Devos D, Segers P, et al. Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol. 2006;112:353–8.

    Article  PubMed  Google Scholar 

  22. Hoffmann A, Rybczynski M, Rostock T. Prospective risk stratification of sudden cardiac death in Marfan’s syndrome. Int J Cardiol. 2013;167:2539–45.

    Article  PubMed  Google Scholar 

  23. Meijboom LJ, Timmermans J, van Tintelen JP, et al. Evaluation of left ventricular dimensions and function in Marfan’s syndrome without significant valvular regurgitation. Am J Cardiol. 2005;95:795–7.

    Article  PubMed  Google Scholar 

  24. Savolainen A, Kupari M, Toivonen L, et al. Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med. 1997;241:221–6.

    Article  CAS  PubMed  Google Scholar 

  25. Aydin A, Adsay BA. Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations. PLoS One. 2013;8:1–10.

    Article  Google Scholar 

  26. Cañadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome. Part 2: treatment and management of patients. Nat Rev Cardiol. 2010;7:266–76.

    PubMed  Google Scholar 

  27. Devereux RB. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons >15 years of age. Am J Cardiol. 2012;110:1189–94.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Yetman AT, Bornemeier RA, McCrindle BW. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol. 2003;41:329–32.

    Article  PubMed  Google Scholar 

  29. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.

    Article  PubMed  Google Scholar 

  30. Pyeritz RE. Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart. 2009;95:173–6.

    Article  PubMed  Google Scholar 

  31. Boodhwani M, Andelfinger G, Leipsic J, et al. Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. Can J Cardiol. 2014;30:577–89.

    Article  PubMed  Google Scholar 

  32. Benedetto U, Melina G. Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis. Heart. 2011;97:955–8.

    Article  PubMed  Google Scholar 

  33. Gersony DR, McClaughlin MA. The effect of beta-blocker therapy on clinical outcome in patients with Marfan’s syndrome: a meta-analysis. Int J Cardiol. 2007;114:303–8.

    Article  PubMed  Google Scholar 

  34. Habashi JP, Judge DP. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Groenink M. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J. 2013;34:3491–500.

    Article  CAS  PubMed  Google Scholar 

  36. Lacro RV, Dietz HC, Sleeper LA, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med. 2014;371:2061–71.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Chung AW, Yang HH, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and −9. Circ Res. 2008;102:e78–385.

    Article  Google Scholar 

  38. Silversides CK, Kiess M, Beauchesne L, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol. 2010;26:e80–97.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Williams A, Davies S, Stuart AG, Wilson DG, Fraser AG. Medical treatment of Marfan syndrome: a time for change. Heart. 2008;94:414–21.

    Article  CAS  PubMed  Google Scholar 

  40. Iravanian S, Dudley Jr SC. The Renin-Angiotensin-Aldosterone System (RAAS) and cardiac arrhythmias. Heart Rhythm. 2008;5:s12–7.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Xu H-Y, Xu Y-Z, Ling F, et al. Application of CRT-D in a Marfan syndrome patient with chronic heart failure accompanied by ventricular tachycardia and ventricular fibrillation. Zhejiang Univ-Sci B (Biomed & Biotechnol). 2013;14:759–62.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular and Cell Sciences Research Institute, St George’s, University of London, London, UK

    Yukiko Isekame MB & Sabiha Gati MBBS, MRCP

Authors
  1. Yukiko Isekame MB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabiha Gati MBBS, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yukiko Isekame MB .

Editor information

Editors and Affiliations

  1. Cardiovascular & Cell Sciences Research, St George's, University of London, London, United Kingdom

    Anne H. Child

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag London

About this chapter

Cite this chapter

Isekame, Y., Gati, S. (2016). Cardiac Management. In: Child, A. (eds) Diagnosis and Management of Marfan Syndrome. Springer, London. https://doi.org/10.1007/978-1-4471-5442-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5442-6_6

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5441-9

  • Online ISBN: 978-1-4471-5442-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation